Nā insulins o kēia mau lā i ka mālama ʻana i nā keiki me ka maʻi type i ka maʻi diabetes mellitus: "No ke" a "Ka" kūʻē "i ka ʻatikala piha o ka ʻepekema ʻōlelo kūwaho.

antagonist B. cepacia AB 1934 a me 8 mau mea like o B. thailandensis 295, ka mea i hōʻike ʻia e ke pio ʻana i ke kanamycin, akā mau nō ka pale ʻana i ka chloramphenicol a ma ka manawa like i loaʻa i ka auxotrophy, ka mea i hōʻike i ka hoʻohui ʻana o Tn9 i ka chromosome. ʻO ka wehewehe ʻana i kā lākou mea e pono ai e like me ke kāmina ʻo Fetiday i hōʻike ʻia ai ka hoʻohui ʻana o nā mutpos transposon e hilinaʻi ana i ka proline a i ka glutamine. I ka hala o nā manawa, ua huli ka ʻāpana o nā clon StK i ka prototrophy, ʻo ia paha ma muli o ke neʻe o ka transposon ma ka chromosome.

Hōʻike kēia hana i ka hiki a me nā kūlana o ka hoʻouna ʻana i ka wā o ka hui o plasmid Rts1 :: Tn9 mai E. coli KS 707 (Rts1:: Tn9) a B. cepacia AB 1934 a me B. thailandensis 295 mau kahe me ka pihi o 6 × 10-8 no nā mea hoʻoliʻi ka mea i loaʻa. . ^ E Ha yM. Ua loaʻa ka haehae a me ke kū polikika plasmid i ka hopena, ua hoʻoholo ʻia nā mea hoʻonā e hōʻike ʻia nei i ka host hou, e hoʻonui ana i ka pale ʻana o ke aho i ka kanamycin a me ka chloramphenicol e 3-6 mau manawa. Ua hōʻike ʻo Transconjugates i ka emi ʻana o ka hanohano no nā hamsters gula a me ka cytopathogenicity no P aculeata. Hōʻike ʻia ka hiki o ka hoʻohui ʻana iā Tn9 i ka chromosome.

No laila, hiki iā mākou ke manaʻo i ka plasmid Rts1 :: Tn9, a me ka plasmids P-1 o ka hui hoʻohui, hiki ke hoʻohana i nā haʻawina genetic o burkholder.

1. Voronina O. L., Chernukha M. Yu., Shaginyan I.A. et al. // Molecular Genetics, Microbiology a me Virology. - 2013. - Helu 2 - S. 22-30.

2. Kalinkina E.V., Ageeva N.P., Merinova O.A. et al. // ʻO nā pilikia o nā pōpilikia he nui. - 2008. - No. 96 - S. 32-35.

3. Molchanova E.V., Ageeva N.P. Patent no ka ʻimi ʻana no 2485182 Kahi ala no ka nānā ʻoli ʻole i ka ʻike ʻana i ka maikaʻi o nā mana o ka burkholderia pathogenic e pili ana i ka cytopathogenicity / kau ʻia 23.01.2012.

4. Morozova M.V., Merinova L.K., Seimova I.K. et al. // Bulletin of the Volgograd Scientific Center of RAMS. - 2006. - No. 1. - S. 38-40.

5. Peters M. K., Shipovskaya N. P., Merinova L. K. // Nūpepa Microbiological. - 1983. - T 45. - V. 3. - S. 11-14.

6. Coenye T., Vandamme P. // puni. Nā Microbiol. - 2003. - Vol. 5. - P 719-729.

7. Deshazer D. // FEMS Microbiol. Helu. - 2007. - Vol. 277 (1). - P 64-69.

8. Murata T., Ohnishi M., Ara T., et al. // J. Bacteriol. - 2002. - Vol. 184. - P 3194-3202.

Molchanova Elena Vladimirovna - K. b. n., i.

s e n s e ʻO ka hale waihona kolamu FKUZ Volgograd Research Anti-Plague Institute of Rospotrebnadzor, kōkua o ke Keʻena ʻo Molecular Biology and Genetics, Volgograd State Medical University e-mail: [email protected]

KAHIKO ʻO kā KAʻĀNUI MAKAʻI ANA I NĀ O ANEA MA KA DIABETES MELLITUS TYPE I: "NO" MA "AGAINST"

N. Yu. Otto, G. R Sagitova, M. Ya. Ledyaev

ʻO ka haukapila ʻo nā keiki kamipila no ka inoa ma hope N.N. Silishcheva, Astrakhan,

ʻOihana Hoʻonaʻauao ʻo Astrakhan State,

Ke Kula ʻOihana Volgograd State

ʻO kekahi o nā hui i ka hoʻomaikaʻi ʻana i ka maikaʻi o ke ola o nā maʻi e manaʻo ʻia he terapi insulin ua koho maikaʻi ʻia. E pili ana i kā mākouʻike loea pilikino, ua noi ʻia ke ala o nā loiloi o ka hoʻohana ʻana i ka insulin, e pili ana i ke ʻano o ka lāʻau lapaʻau, ka makahiki o ke keiki, a me ka moena o ka haukapila.

ʻO nā huaʻōlelo nui: nā keiki, ke ʻano type like diabetes mellitus, insulin therapy.

PROS KA HANA O KE KAI LOA O KA MAU ANA I KE KĀHATLĀ HOU O KA ANAKANA A TYPE I DIABETES

N. Yu. Oio, G. R. Sagitova

Kūpono maoli ʻia ka pae ʻana o ka inehini i manaʻo ʻia he mea nui ia e hoʻomaikaʻi ai i ke ʻano o nā mea maʻi. Manaʻo mākou i nā ala kokoke i ka hoʻohana pono ʻana i ka insulin e like me ke ʻano o ka lāʻau lapaʻau, ʻo ka makahiki o ke keiki e kau ai ma luna o kā mākou ʻike loiloi.

ʻO nā huaʻōlelo nui: nā keiki, ke ʻano type o ka maʻi diabetes, ʻenehana insulin.

ʻO ke aʻo ʻana i nā pilikia e pili ana, i waena o alia, i ka hana ʻāina a me ke aupuni 1, 2. ka maʻi wikiwiki, ʻoi aku hoʻi i nā keiki, ʻike ʻia ke kumu o ka maʻi.

Pono 4 (48). 2013 57

poino nui o ka insulin. ʻO ia ke kumu i ka hoʻololi ʻana i ka lāʻau nīnēnē e waiho wale ana i ka maʻi no ka maʻi diabetes i ke ʻano keiki. Mai ka makahiki 2012, ka mana o ka papa inoa o nā lāʻau lapaʻau a me nā mea pono maoli, i ʻae ʻia e ka Hoʻoholo ʻĀina o ke Aupuni o ka Russian Lūkī o Dekemaba 7, 2011 No. 2199-r, ka mea e komo ai ka insulin. ʻO ke koho kūpono ʻoi aku ka maʻi maʻamau no ka maʻi diabetes II ua ʻike ʻia i ka hoʻonui ʻia ʻana o ka inika insulin - kahi ʻano nui o nā inikini o ka nui o ka insulin e hoʻohālike i ka huna ʻana o ka physiological o ka insulin. ʻO ka mālama ʻia he administrant subcutaneous o ʻelua mau ʻano o ka insulin. ʻO nā pinepine pinepine kēia o ka hoʻohana ʻana o ka insulin pōkole (Actrapid a Humulin Regular) a i ka ultrashort (NovoRapid a Humalog) paha, e lawelawe ʻia ma mua o nā kīʻaha nui (ke ʻano ʻano like o ka huna ʻana i ka meaʻai) a me ka insulin medium-Duration (Protofan, Humulin NPH) a i ʻole hana lōʻihi (Lantus) ( ka hoʻokō ʻana i ka hūnā nui a kumu paha ʻole. Hoʻomaopopo ʻia ʻo 1-2 mau manawa i ka lā 3, 5. Ua lohe ʻia nā Endocrinologists e hoʻomaʻamaʻa i nā kauka e pili ana i nā pōmaikaʻi nui o nā "insulins" hou "i nā mea kahiko", e hoʻāʻo e haʻalele ʻē i nā insulins genetically engineered (biosynthetic) mua, e like me Actrapid a me Protofan (hui ʻO Novo Nordisk, Denemaka), Humulin Kūʻai a me Humulin NPH, (Eli Lilly, USA). ʻO ka hoʻololi i ka hoʻohana ʻana i nā insulins o nā hui like ʻole, akā hana o ka hana ultrashort (analogues kanaka) - insulin Aspart (inoa inoa Novorapid) a me insulin Lizpro (Humalog), i hōʻoia ʻia e ka hana wikiwiki lākou. ʻO nā insulins lōʻihi e hana nei i ka mālama ola olakino, ʻo Glargin (Lantus) (Aventis, Kelemānia) a me Detemir (Levemir) (Novo Nordisk, Danemaka) e hoʻohana nui ʻia i ka mālama ʻana. Loaʻa ka maikaʻi o nā insulins ultrashort, ʻaʻohe pono e kū i ka manawa ma mua o ka ʻai ʻana, e loli wale nā mea maʻi i ka pūnana a me ka manawa e ʻai ai, a he mea koʻikoʻi loa kēia mai ka hiʻona o ka loiloi ʻana i ka maikaʻi o ke ola o nā maʻi. Lantus kahi insulin 24-hola i lawelawe ʻia i hoʻokahi lā, i ka ʻokoʻa me nā insulins medium-hana (Protofana lāua ʻo Humulin NPH), i lawelawe ʻia i ʻelua (kakahiaka a me ke ahiahi), ka mea, i ka ʻohi ʻana i ka nui o nā inikō. ʻO kahi wale nō o nā insulins o kēia wā, ʻo ke kumukūʻai, ʻo ia hoʻi, ma mua o ke kumu kūʻai o Actrapid a me Protofan a me Humulin ma mua o 3 mau manawa.

ʻO ke aʻo ʻana i nā hiʻohiʻona o ka insulin, e noʻonoʻo ana i ka helu o nā lā i hoʻopau ʻia e nā mea maʻi me ka maʻi diabetes type type i ka haukapila a me ka makeha o kēlā me kēia lā o ka insulin e like me ka makahiki.

Ua nānā ʻia kahi hōʻike kikoʻī o nā palapala olakino (form 112, form 003 / y) o nā keiki he 144 a me nā ʻōpio

o ka maʻi mellitus o ka maʻi mellitus i nānā ʻia a mālama ʻia ma ke keʻena ʻo Endocrinology i ka makahiki 2012. I nā hoʻohana hou ʻana i ka mālama ʻana i ka hoʻoponopono hou ʻana o ka ʻenehana o ka "hanauna" hou: kahi hana ultrashort Humalog a i Novorapid (70%) i hui pū me ka Lantus insulin lōʻihi (50%) a i 1/5 nā keiki i hui pū me Levemir. ʻO nā "insulins" kahiko, e like me Humulin - Kūlike a me NPH. ua loaʻa ma mua o kahi hapaha o nā keiki, a me Actrapid a me Protofan 4% o nā keiki. ʻO ka pinepine, ka hui pū ʻana o nā insulins pōkole a me nā mea lōʻihi - Actrapid + Protofan, Humulin Regular + Humulin NPH, ultrashort a lōʻihi insulin-Humalog + Lantus a me Novorapid + Levemir (95%). Hoʻohana maʻamau: Humulin Regular + Lantus, Actrapid + Lantus, Actrapid + Levemir, Novorapid + Lantus (5%), kahi i pili me ka hāʻawi ʻana i ka hoʻomākaukau ʻana i ka insulin i ka wahi e noho ai. I nā keiki a me nā ʻōpio 11-17 mau makahiki, ka hanauna hou o nā insulins - Humalog a me Lantus - i hoʻohana pinepine ʻia, i nā keiki o ke kula mua 7-10 makahiki - Novorapid a me Levemir, i nā keiki ʻōpio - Humulin Regular a me Humulin NPH. Kēia koho maikaʻi o ka insulin i nā ʻōpio o nā makahiki ʻōpio na ke alakaʻi maikaʻi ʻia o HumaPen a me nā penikala syringe penehine o Novo-Pen me kahi wahi haʻahaʻa o 0.5 mau ʻāpana. Ke nānā nei i ka hōʻailona o ka helu o nā lā moena i ka wā o ka maʻi lapaʻau, ua ʻike mākou i ka hihia o ka hoʻohana ʻana i nā insulins ultra-pōkole a me nā poʻe pōkole (Humalog, Novorapid, Actrapida, Humulin Regular), ʻo ka liʻiliʻi liʻiliʻi ka noho ma kahi moe i mālama ʻia i ka wā me ka Novorapi-hale - maʻamau ka lā moe 16.6 ka nui loa - me ka mālama ʻana iā Humalog - 18.5. ʻO ka pōkole o ka noho ʻana o ka moena pōkole i ʻike ʻia i ka wā e hoʻohana ana iā Humalog i ka hui o nā keiki 11-14 makahiki, ʻo Novorapida - i kahi hui o 4-6 makahiki, ʻo Humulin Regular - i ka hui o 4-6 makahiki, Actrapida i nā makahiki 15-17 mau makahiki. Ke hoʻohana nei i nā insulins o ka lōʻihi lōʻihi a me nā hana lōʻihi (Protofan, Humulin NPH, Lantus, Levemir), ʻo ka liʻiliʻi liʻiliʻi i ʻike ʻia me kā Protofan hoʻomaʻamaʻa - ʻo 16.2 ka nui o kahi moena hiamoe o 162 mau lā, a ʻo ka nui loa me Lantus-mālama - ʻo ia ka moe-awā ʻo 188. ʻO ka lā pōkole ʻoi loa i ka wā e hoʻohana ai ʻo Lantus i kahi pūʻulu o 7-10 mau makahiki, ʻo Levemira - i ka hui o 4-6 mau makahiki a me 15-17 mau makahiki, ʻo Protofana - i loko o ka pūʻulu 15-17 mau makahiki, ʻo Humulin NPH - i ka hui o 4-6 mau makahiki. ʻO ka lā lōʻihi loa o ka moena e hoʻohālikelike no ka makahiki 11-14 mau makahiki (kahi i pili ʻia me ka manawa o ka kaumaha hormonal) a ʻo 20.2 mau lā hiamoe. I ka hopena me nā insulins ultrashort, ʻo ka nui o ka nui o kēlā me kēia lā o 15 (Novorapid) he 17 mau ʻāpana (Huma log) a no ka "kūpuna" hanauna o ka insulin hana pōkole, ʻo ka nui o ka nui o ka lā o ka insulin o 15.8 (Humulin Regular) - 17.7 mau ʻāpana (Actrapid). ʻAʻole loaʻa nā pōʻino o ka "insulins" lōʻihi "i ka hopena: ka awelika o kēlā me kēia lā he 12.3 (Levemir) he 13.1 mau ʻāpana (Lantus), a me ka" lama "

Pono 4 (48). 2013

ka awelika awelika o ka awelika o ka lā maʻamau o 12.7 (Humulin NPH) he 13.9 mau ʻāpana (Protofan). No nā mea āpau, hoʻokahi mea ʻokoʻa: ka hoʻonui ʻia ʻana o ka nui i ka makahiki, he "kuʻi" nui ka wai o ka insulin i ka manawa 1.5-3, e hāʻule ana i ka makahiki o 7–14 mau makahiki, i hoʻohālikelike ʻia me nā keiki preschool. No nā keiki liʻiliʻi (1-3 mau makahiki), ka palena haʻahaʻa o kēlā me kēia lā no kēlā me kēia insulin (4-8 mau pūʻulu), a me ka nui loa - no ka makahiki 15-17 mau makahiki (17-28 mau pūʻulu). Ke hoʻohana ʻia nei nā insulins ultra-pōkole a me nā insulins pōkole (Humalog, Novorapid, Aktrapid, Humulin Regular), ʻo ka liʻiliʻi loa ka nui o nā lā o ka lālia i kēlā me kēia no Humalog i nā makahiki he 1-3 o ke ola (5.1 mau ʻina), Novorapid ma 7-10 mau makahiki (13 , 2 mau ʻona), Actrapida i 7-10 mau makahiki (14.0 mau ʻāpana). Ke hoʻohana nei i nā insulins o ka lōʻihi lōʻihi a me ka lōʻihi (Protofan, Humulin NPH, Lantus, Levemir), ʻo ka palena haʻahaʻa o ka lā i ka lā o ka insulin i ʻike ʻia ma Humulin NPH i 1-6 mau makahiki o ke ola - 4 mau pūʻulu. I ka makahiki 7-10 mau makahiki, ʻo ka hopena o Lantus a me Levemir he 1.5 mau manawa ma mua o ka hoʻohana ʻana i nā insulins medium-duration (Protofan ma NPH). Ke manaʻoʻiʻo nei mākou i ka makahiki 11-14, ʻoi aku ka maikaʻi o ka hāʻawi ʻana iā Lantus, no ka mea he haʻahaʻa loa ʻo ia i ka wā e hoʻohana ai (ʻāpana. 13.2). I 15-17 mau makahiki, ka haʻahaʻa loa loa i ka wā e hoʻohana ai i ka Protofan (17 mau ʻāpana) a me Lantus (17.8 mau ʻāpana).

1. ʻAʻole i emi ka nui o ka lōʻihi o ka noho ʻana i kahi moena a me ka hoʻohaʻahaʻa ʻana i ka nui o nā awelika i kēlā me kēia lā ke hoʻohana ʻia nā insulins "hou".

2. Hoʻomaka i ka hopena o ka lāʻau ma ka hapa o ka moena ai ka la a me ka inikua o kēlā me kēia lā o ka insulin, manaʻo mākou e hoʻohana ana i kēia aʻe ʻoi aʻe ka hopena: Hiki i ka Humalog ke ʻōlelo ʻia i nā makahiki he 1-3 a me 11-14 mau makahiki, ʻo Novorapid i 4-10 mau makahiki, hiki ke ʻōlelo ʻia i ka Humulin Regular 4-6 mau makahiki, ʻo NPH ma ka 1-6 mau makahiki, ʻo Leva-honua 4-10 a me 15-17 mau makahiki, ʻo Lantus ma 7-17 mau makahiki heʻehā, Actrapid i 7-10 mau makahiki, ʻo Actrapid lāua ʻo Protofan (e kūʻē i nā ʻōlelo hōʻike o kēia wā) 15-17 mau makahiki . ^ E Ha yM.

1. Dedov I.I., Kuraeva T. L., Peterkova V. A., Shcherba-cheva L. N. Diabetes mellitus i nā keiki a me nā ʻōpio. - M .: Pukaiao Kumukanawai, 2002 .-- 203 p.

2. Dedov I.I., Melnichenko G.A. Nā hoʻoponopono papaʻaina. Endocrinology. - M.: Litterra, 2007 .-- 85 p.

3. Dedov I.I., Peterkova V.A., ʻO Kuraeva T. L. ʻ L.lelo ʻ onlelo Lūkia ma ka mālama ʻana i ka maʻi maʻi i nā keiki a me nā ʻōpio. // Farmateka. - 2010. - ʻAʻole 3. - S. 7-10.

4. Algorithms no ka mālama pono ʻana i nā poʻe maʻi me ka maʻi mellitus // Diabetes. - 2011. - Nu. 3 (pili.).

5. Ahahui ʻAmelika Hui Pūʻāina ʻo ʻAmelika. Nā Kūlana o ka Nila mālama maʻi ma ka maʻi hānai // Diabetes Care. - 2009. - Vol. 32 (Kumuhana 1). - P. 13–61.

Otto Natalya Yuryevna - ke Keʻena o ke Keʻena ʻo Endocrinology o ka Halemana Hōʻali Kānāwai Hui Pūnaewele i kapa ʻia ma hope N. N. Silishcheva ”, e-mail: [email protected]

KE KAHANA NO KA PONO O KA PONO A MAU NUI I KOLOKOLO OXIDATIVE I KE KANA O KA PAUKU O PYELONEPHRITIS I KE ANA

Kulanui ʻOihana Kauka Pūnaewele ʻo Smolensk

Hōʻike ʻia nā ʻikepili noiʻi i nā ʻōnaehana preexidant a me nā antiioxidant ma nā keiki 79, nona 49 mau keiki he mau pyelonephritis me 30 mau keiki olakino ʻoi aku 1 a 17 mau makahiki he nui. Ua hōʻike ʻia nā hana hoʻomohala o ke kūkulu ʻana a me ke kaʻina o ke kaumaha o ka oxidative stress ma pyelonephritis ma kona papa.

ʻO nā huaʻōlelo nui: pyelonephritis, nā keiki, ke kaumaha oxidative, reactive oxygen species, antioxidant defense, chemiluminescence.

KE KAHANA NO KA PONO O KA PONO A MAU MOLO O KA OOTOHU MA KAHI ANA I KE KANA O KA PONELONEPHRITIS i KANA

Hōʻike ka ʻatikala i nā ikepili o kahi noiʻi o nā ʻōnaehana prooxidant a me nā pūnaehana antioxidant i ka 79 mau keiki, ʻo 49 nā keiki me ka neʻe o ka pyelonephritis, a me 30 mau keiki ola olakino mai 1 a 17. ʻO nā hiʻohiʻona o ka maʻi oxidative ma pyelonephritis, hilinaʻi i kāna papa, mea hoʻoholo.

ʻO nā huaʻōlelo nui: pyelonephritis, nā keiki, ke kaumaha oxidative, reactive oxygen species, antioxidative protection, chemiluminescence.

I ke kiko o nā pathology i loaʻa, ʻo ka uritation excretion ka lonephritis. ʻO nā kaʻina manuahi manuahi ka mea hoʻokahi o nā ʻōnaehana hoʻonāukiuki i ka ʻōnaehana kino ma nā keiki.

ʻO ka maʻi mellitus type 1: nā hōʻailona, ʻai a me ke kāohi ʻana i ka maʻi ʻaʻala I

No ka mālamaʻana i nā hui pū, ua hoʻohana maikaʻi kā mākou mea heluhelu iā DiabeNot. Ke ʻike nei i ka kaulana o kēia huahana, ua hoʻoholo mākou e hāʻawi iā i kou makemake.

Hoʻokahi mau makahiki i hala aku nei, ua manaʻo ʻia ka maʻi diabetes i nā maʻi e pili ana i ka wāʻelemakule - i ka wā ʻōpio, ua liʻiliʻi wale ka poʻe i loaʻa iā ia. Eia nō naʻe, ʻo kēia manawa aia ka manaʻo e hāpai i ka hoʻomohala ʻana i ka maʻi diabetes i nā wā ʻōpio. Nā kumu no ka hoʻomohala ʻana i ka maʻi i ka poʻe ʻōpio a me ka poʻe ʻōpio i ʻole: inā me ka wā he mau kēia i ka palu nui ʻana o nā hana kino, ʻo ia hoʻi ka pancreas, a laila ma ka ʻōpio ʻōpiopio, ʻo ia kēia no ka nele o ka insulin. Ma mua, ua kapa ʻia kēia ʻano maʻi maʻi "insulin-dependence diabetes mellitus." I kēia manawa ua lilo i mea maʻamau - type type 1 diabetes. ʻO kahi maʻi metabolic ka mea i hōʻike ʻia e ka maʻi hyperglycemia.

ʻO ka pae o nā huaʻōlelo: ʻo ka hyperglycemia kahi hōʻailona maʻi e hōʻike ana i ka nui o nā kiko o ka glucose (gula) i ka serum o ke koko.

ʻO ka ʻokoʻa nui ma waena o ka maʻi maʻamau o ka maʻi type a me ka maʻi diabetes type 2, ma ka lua o ke kekona, hiki ke kino kūʻokoʻa ke kino i ka insulin a, ma muli, hōʻemi iki ka hoʻoluʻu i ke koko koko. I ka lā mua o ka maʻi, ʻaʻole i kū mai ka insulin i ke kūʻokoʻa a hoʻomau pono ka mea maʻi i ka lawe ʻana i nā lāʻau hoʻohiolo mauʻu a me nā inikini insulin.

Hoʻomaka ka maʻi mellitus type 1 ke ʻano maʻamau me kahi papa o ka maʻi i hiki ai i ka mea maʻi ke kapa aku i ka lā i ʻike ʻia nā hōʻailona mua o ka maʻi hyperglycemia:

Putu maloʻo
Kahuna
Pāʻai wikiwiki.

ʻO kahi poho momona koʻikoʻi, i kekahi manawa e hōʻea i ka 10-15 kg i kēlā me kēia mahina, ʻo ia kekahi o nā hōʻailona o ka maʻi maʻi maʻi 1 ka maʻi.

No ka hōʻoia i ka hōʻikeʻana, ua kuhikuhi ʻia kahi loiloi biochemical i ke koko a me ka urine. Inā hōʻike nā hōʻike i ke kū i ke koko koko kiʻekiʻe, a me ka acetone a me ka glucose i loaʻa i ka urine, ua hōʻoia ʻia ka maʻi.

ʻO ka maʻi diabetes type 1 kahi maʻi autoimmune, a hui pū pū kekahi me nā maʻi like ʻole - hoʻōla i ka goiter toxic (maʻi Graves), autoimmune thyroiditis.

ʻO ka papa o ka maʻi

ʻOiai ʻo kahi hoʻomaka koʻikoʻi kahi, hoʻomohala ikaika i ka maʻi diabetes-hilinaʻi. ʻO ka manawa maʻamau, i ka manawa maʻamau no kekahi mau makahiki. A aia wale nō a hiki i ka luku ʻia ʻana o nā 80-cells ke 80% e hoʻomaka i nā hōʻailona lapaʻau.

Ka mea iʻike ʻia i nā huaʻōlelo: β - nā ʻāpana - kekahi o nā ʻano o nā huaʻala o ka pancreas endocrine. Mālama nā huaola Beta i ka insulin hormone, e hoʻohaʻahaʻa i nā glucose koko.

I ka hoʻomohalaʻana o ka maʻi diabetes type 1, ʻokoʻa mau ʻānana e 6:

ʻO keʻano o nā predisposition genetic. Pono e ʻike ʻia he 2-5% wale nō o ka poʻe i loaʻa he predisposition genetic ke hoʻohuli i ka maʻi diabetes 1 maoli maoli no ia. I mea e loaʻa ai nā ʻike hilinaʻi ma ka predisposition o ka maʻi, pono ia e hana i kahi hōʻike o nā hōʻailona genetic o ka maʻi. Ke hōʻike nei nā hanana o ka HLA e hōʻike nei i ka nui o ka hōʻemi o ka hoʻomohala ʻana i ka maʻi diabetes-kiʻekiʻe. I loko o ka serum, ua loaʻa kēia mea hōʻailona i ka 5-10 mau makahiki ma mua o nā hōʻike mua o nā maʻi.
ʻO ka hoʻomaka ʻana o kahi kaʻina autoimmune. ʻO nā mea o waho e hiki ke hoʻowalewale i ka hoʻomaka ʻana o ka maʻi hiki i nā maʻi - nā maʻi ʻehā (mumps, rubella, cytomegalovirus), nā lāʻau lapaʻau, ke kaumaha, nā meaʻai maikaʻi - nā hoʻohana ʻana i ka waiū i ka waiū me nā kahu ʻai holoholona i ka hoʻopili ʻana, nā huahana nā nitrosamines. Ma 60% o nā hihia, ʻo ia nā mea o waho nā mea i lilo ka pihi hoʻomaka no ka hoʻomohala ʻana i ka maʻi type 1. ʻAʻole i kū ʻia ka ʻaihue pancreatic insulin i kēia manawa, akā, ua hoʻoholo mua kahi hōʻike immunological i ka hele ʻana o nā antibodies.
ʻO ka hoʻomohalaʻana i nā maʻi maʻi immunological. I kekahi manawa i kapa ʻia ʻo ka insulin autologous maʻamau.I kēia manawa, ʻaʻohe mau mea hoʻohuli metabolic, akā hoʻomaka koke ka luku ʻana i nā cell betta. I loko o ke koko aia nā loea auto-antibodies i nā ʻano like ʻole o nā β-cells - ka auto-antibodies i ka insulin. ʻAʻohe o kēia helehelena i nā hōʻailona maʻamau. I ka maʻi (maʻamau (hoʻokaʻawale ʻia kahi hōʻike hoʻonaninani intravenous glucose), ʻike ʻia ka nalowale o ka hana mua ʻana o ka inikini insulin.
ʻO ka maʻi maʻi immunological koʻikoʻi - latent diabetes mellitus. ʻOiai ke kī ʻole o ka hoʻohaʻahaʻa glucose, ʻaʻohe mau maʻi o ka maʻi maʻi o ka maʻi maʻi. Hōʻike ka hoʻāʻo ʻana o ka hoʻonaʻauao waha ma ka hoʻonui ʻana i ke kaena nohona wikiwiki, ma muli o ka luku ʻia ʻana o ka hapalua o nā hapa o nā β-cell. Hoʻomaʻi pinepine nā poʻe maʻi i kēia manawa i ka malaise, hōʻano hou i ka furunculosis, conjunctivitis.
ʻO ka maʻi mellitus o ka maʻi ʻokiʻoki o ke ʻano mua me ke koena huna o ka insulin. Ma kēiaʻano, e hōʻike piha nei nā hōʻailona āpau o nā maʻi. He maʻi nui ka maʻi - ʻole ke mālama kūpono, ma hope o 2 mau hebedoma e ulu ana kahi maʻi make - ketoacidosis maʻi maʻi. Hoʻopau ʻia nā luku β-cells i ka 80-90%, akā naʻe ke mālama nei ke koena o ke kaila o ka insulin. Inā hoʻomaka ka hoʻomakaʻana o ka insulin, ma kekahi mau mea maʻi e hoʻomaka ana i kahi manawa paʻa o ka maʻi - ka "meli", ka mea, e hōʻike ʻia e ka nui o ka pono o ka insulin exogenous.
Hoʻololi i ka maʻi mellitus mole me ka emiʻole o ka insulin - ka maʻi diabetes. Ua hiki i ka luku ʻia o nā β-cell i kahi pae koʻikoʻi, hoʻōki ka huna ʻana i ka insulin i ke kino. ʻAʻole hiki ke ʻona ne ka metabolism maʻamau me ke ʻano ʻole o ka dosis maʻamau o ka insulin.

ʻAʻole i loko o nā hihia a pau o ka maʻi mellitus o ke ʻano, ua mālama ʻia kahi hoʻomohala nui o ka maʻi.

ʻO ka lapaʻau ʻana no ka diabetes mellitus-dependant mellitus

ʻO ka mālama ʻana o ka maʻi maʻi type 1 ka mea paʻa loa ka meaʻai a me nā inikini maʻamau maʻamau a i ʻole ke lawe ʻana i nā lāʻau hoʻohiolo i ke kō. ʻO ka mea kaumaha, ʻaʻole ke maʻi ka maʻi diabetes. ʻO ka pahuhopu o ka noʻonoʻo ʻana e mālama i ka hana maʻamau o ke kino a pale i ka hōʻalo ʻana o nā ʻōpiopio.

Inā hoʻoholo pololei ʻia ka makeʻana o ka insulin, ʻaʻohe mau ʻokoʻa kūikawā mai ka papa o kahi kanaka maʻamau. ʻO kahi ʻokoʻa nui ka pono o ke ana ʻana e lawe i ka nui o nā kinikona digestible maʻalahi. Hiki kēia iā ʻoe ke helu i ka nui o ka insulin i koi pono ʻia.

Hoʻololi like ka meaʻai e like me ka hiki.
ʻO ka papaʻai ʻona maikaʻi loa - ma kahi o 4 mau manawa i ka lā, i nā mahele liʻiliʻi.
ʻO ka ʻāpana maʻamau ma ka ʻahaʻaina he 500-600 mau calorie, inā he pono e hoʻemi i ka paona, a laila emi
Hiki ke hoʻonui ʻia ka nui o nā hāmeʻe i ke wā o ka hoʻoikaika kino - e hele ana i ka ʻāina, e hoʻomaʻamaʻa ana,
Pono e hāʻawi i ka makemake i nā ipu kukū. Maʻa momona, pīpī, spicy, ulaula - wale nō i loko o nā nui helu.

Nui! Mai kuhi i ka ʻai me ka maʻi maʻi maʻi i kekahi hihia. E like me ka overeating.

Pono e mālama pono i nā huahana me nā mea momona - aia kekahi o lākou i ka liʻiliʻi o ka calorie ma mua o ke kō. ʻO nā mea momona haʻahaʻa i loaʻa i ka aspartame, saccharide, stevioside, cyclamate. ʻO ka Fructose, xylitol a me sorbitol ka nui o nā kalana. Mai poina e lawe nā mea aloha i ka wā e helu ana i nā kūmole o ka insulin, a ʻaʻole like nā mea āpau, akā like ka maʻi a me ka pono o ka fructose e like me ka like.

He mea paʻakikī loa ka pili ʻana i ka papaʻai no nā keiki maʻi a me nā ʻōpio. Ma ka ʻaoʻao o nā mākua, pono ka mālama mau ʻana i ʻole e ʻai ke keiki i ka meaʻai i papa ʻia a ʻaʻole e hoʻonāukiuki i nā hoʻopiʻi koʻikoʻi.

ʻO nā huahana e pāpā i ka diabetes mellitus o nā ʻano mua: sīkē, biscuits, honi, jam, keʻa a me nā mea like ʻole, aia ka nui o nā pika ʻawaʻawa. Nā huaʻai - hua waina.

Pono e helu ʻia ka nui o ka insulin i kēlā me kēia meaʻai a me kēlā me kēia lā, ʻoiai inā ʻaʻole ka ʻokoʻa o ka papa i nehinei i kēia lā. ʻO kēia ke kumu o ka hōʻoia no ka hoʻololiʻana o ka insulin i ka wā o ka lā.

Hoʻolohe Alkohol!

ʻAʻole pāpā ʻia nā wai liʻiliʻi o ka waiʻona no ka maʻi maʻi mika 1. ʻO ka pilikia nui o ka inu ʻona ma ke ʻano o ka inu ʻana, ʻaʻole hiki i ke kanaka ke mālama i kona ʻano a ʻaʻole ʻike ʻo ia i nā hōʻailona pōpilikia o ka hoʻonui ʻana o ke kō i ke koko i ka manawa a ʻaʻole ia e hana i ka inikua o ka insulin.

Eia kekahi, ʻo ka'āina hypoglycemic a me kāna mau hōʻailona e hui pū me nā hōʻailona o ka hoʻohālikelike - ʻōlelo hilahila, koikoʻi ʻana o ka neʻe ʻana o ka neʻe. A inā hoʻomaka kēia ʻano i kahi wahi ākea, ʻaʻole i ʻae ka ʻawa ʻona i kekahi mea e nānā i ka pōpilikia i ke ola o ke kanaka i ka wā pono. Ma muli, ua pono ka manawa e mālama ai i ke ola.

Hoʻohana kino

ʻO ke ʻano kino he kūlana nui loa ia no ke ola maʻamau o kekahi kanaka. Ma ka maʻi mellitus, ʻaʻole contraindicated ʻo ka hoʻōla, akā aia kekahi mau lula e lilo ai i mea maikaʻi no ka kino.

ʻO ke kānāwai mua. Hiki ke hoʻokō kūlohelohe wale aku i ke kūkaʻi ʻana o ka uku no ka manawa lōʻihi no ka maʻi diabetes. I kahi pae koko koko ma mua o 15 mmol / l, ua hoʻomaʻemaʻe ʻia nā hoʻomaʻamaʻa.
ʻO ke kānāwai ʻelua. Me nā hana ikaika - ka hoʻonaʻauao kino, ʻauʻau ʻana, ʻoiai hoʻi i ka diso - pono ʻoe eʻai i ka 1 X.E i kēlā me kēia hapalua hola. ae mai ia. Hiki paha ia i kahi ʻāpana berena, nā ʻākala.
ʻO ke kolu ʻekolu. Inā lōʻihi ka hana kino, pono ia e hōʻemi i ka nui o ka insulin ma o 20-50%. Inā hoʻohaʻahaʻa ka hypoglycemia iā ia iho, a laila ʻoi aku ka maikaʻi o ka hoʻopiʻi ʻana ma ia mea me ka lawe ʻana i nā kaola ʻalā maʻalahi - wai momona, nā wai ʻono
Pule ʻā Hoʻohana maikaʻi ka hoʻomaʻamaʻa ʻana i kekahi mau hola ma hope o ka papaʻai nui. I kēia manawa, haʻahaʻa ka haʻahaʻa o ka uluʻana o ka hypoglycemia.
ʻO ka pauku ʻelima. Pono ka hana pilikino e nānā i nā hiʻohiʻona pilikino o ka mea maʻi - ʻoi aku, hoʻoikaika, ke olakino ākea.

Mālama e inu i kahi wai o ka lawa pono, no ka mea, i ka wā e hoʻomaʻamaʻa nei ka emi ʻana o ke kahe i loko o ke kino e hoʻonui. Pono ʻoe e hoʻopau i nā papa ma o ka hōʻemi ʻana i ka nui o nā hoʻomaʻamaʻa, e neʻe ana i nā mea hoʻomaha. Mālama kēia i ke kino e hoʻomaha iki a hele i kahi ʻano hoʻomaha.

Turmeric no ke ʻano maʻi type like me 2

E pili ana i nā pono o ka turmeric
E pili ana i ka hoʻohana ʻana
E pili ana i nā kūleʻa

Pono ke maʻi mellitus maʻi maʻi kūloko, i pili ka hoʻohana ʻana i nā lāʻau ʻaʻole wale nō i ʻae ʻia e ka loea, akā ʻo ka hoʻohana ʻana i kekahi mau lāʻau lapaʻau kuʻuna. Pono e noʻonoʻo ʻia kēlā ʻano pau loa no ka maʻi type a me ka type 2, e kōkua ana e pale aku i ka pīhoihoi ʻana i ka insulin. I kēia mea, pono e hoʻomaopopo e pili ana nā mea ʻala e like me ka turmeric i kahi hana kūikawā i ka hoʻihoʻi ʻana i ka maʻi maʻi. E pili ana i kāna mau waiwai pono, nā nuances o ka noi a nui aku ma hope o ka kikokikona.

E pili ana i nā pono o ka turmeric

I ka ʻāpono, hiki i ka papa inoa ke kumu no ka lawe ʻana i ka turmeric no ka manawa lōʻihi, no ka mea, he moʻomeheu maikaʻi loa ia e hōʻoia no nā ʻano maʻi mellitus a ʻaʻole e hoʻonāukiuki i ka insulin. He pono ke hoʻokō ʻia ka mālama ʻana me ia, no ka mea,:

iki
hōʻemi i ka ratio o ka cholesterol maikaʻi ʻole a hiki iā ia ke pale aku i ka atherosclerosis,
optimizes ka pale ole
e hana mai i ka pale i ke anuanu, mālama pono iā lākou - hiki ke hoʻohana ʻia nā syringes i insulin no ka hoʻomau,
Hāʻawi i kahi hana ikaika aku o ka ʻōnaehana cardiovascular.

Eia kekahi, ʻo ka turmeric kekahi o nā lāʻau lapaʻau ikaika loa o ka puka kūlohelohe. ʻAʻohe ʻo ia i hiki ke hōʻeha i ka microflora pīpī. ʻO kekahi, lawe pū i kēia ʻano pona no ka mea i loaʻa i nā ʻano anti-inflammatory a hiki ke hoʻemi i ka makemake wale ʻana e ʻai ai i nā meaʻai momona, akā e mālama pū i ka hopena o kēia kaʻina a hoʻopaʻa i ka mālama ʻana i ka insulin. ʻO kēia mau mea āpau, he pono no ka maʻi diabetes, ka lua a me ka lua.

Kuhi pū nā poʻe loea i ka emi o ka hoʻohālikelike o ka glucose i ke koko a me ka hoʻohaʻahaʻa ʻana i ka nui o ka kiko adipose, ʻo ia hoʻi, e hoʻopilikia maoli ana i ke kūlana olakino o ka maʻi maʻi. ʻO ia ke kumu e hoʻokuʻu ʻia ai, a me nā pilikia i ke kino e hoʻoili i ka insulin. Eia kekahi, ʻo ka mālama ʻana i ka turmeric me ka maʻi diabetes e hoʻokaʻawale a ʻaʻole paha e ʻae i ke kūkulu ʻana o kekahi mau hoʻopiʻi i mua o ka maʻi mellitus. Ma keʻano kūikawā, pili kēia i ʻaʻole i ka atherosclerosis wale nō, akā ua pili pū i ka ʻalā.

ʻO ka papa inoa o nā māhele o ka turmeric ka mau huaora e pili ana i ka hui B, C, E a me K, a me nā mea peʻaleʻa, nā antioxidants kūlohelohe a me nā aila pono, pū me ka curcumin. ʻO ia ke kumu i ka lawehala i hōʻike ʻia e kēlā me kēia o ka maʻi maʻi.

Hoʻopili maikaʻi kēia mea waiwai maikaʻi i nā kaʻina metabolic i hiki i ke kino o ke kanaka, no laila ke kūpono ka hoʻohana ʻana iā ia i kēlā me kēia lā. Pono e mālama ʻia ia hana.

ka pale ʻana o nā maʻi like ʻole,
e hoʻonui i ka "maikaʻi" o ka make.

E pili ana i ka hoʻohana ʻana

I ke kaʻina hana o ka turmeric, pono e ʻike ʻia kekahi mau lula.

Hāʻawi ʻia ʻo ia nei kēia mea hoʻohua me ka ʻāpono i ʻōlelo ʻia, ʻaʻole pono ʻoe e lawe ʻia me kāna hoʻohana.

Eia kekahi, inā hele pū kekahi maʻi maʻi o kēlā me nā pilikia me ka gastrointestinal tract, e aʻo ʻia e hoʻohana i ka turmeric ma hope o ka kūkā ʻana me ka loea.

E wehe i ka mālama ʻana me ka curcumin i nā manawa kūpono no ka hoʻohaʻahaʻa ʻana i ka ratio o ke kolamu ma ke koko a me ka hoʻolālā ʻana i ka hana o ke koko. I ka manawa like, ʻaʻole wale ia e hoʻomaʻemaʻe wale, akā e hoʻomaikaʻi ka hoʻouluulu o nā ʻula koko ʻulaʻula, a me ke ʻano o ka pae ʻana o nā platelets. Ma kēia e noʻonoʻo ai, pono e mālama pono kēia mea kuono a me nā kānaka me nā pilikia koko.

Hāʻawi ʻia iā ia i kona hiki ke hoʻokaʻawale i nā mea ʻona a me nā mea ʻawaʻawa mai ke kino, ke ʻōlelo ʻia nei ʻo ia e hoʻohui i ka meaʻai me ka hoʻohana mau ʻana i ka lāʻau lapaʻau a hoʻonui paha i ka mālama ʻana i ka maʻi maʻi. Eia kekahi, pili ka lāʻau lapaʻau no ka hiki ke hoʻopalulu me nā ʻano o nā mea iniseti like ʻole a me nā meaʻala.

Mahalo i kēlā me kēia o kāna mau ho'ōla, turmeric no nā maʻi maʻi o kekahi ʻano.

ʻaʻole wale ia e hōʻemi i ka nui o ka glucose i ke koko,
akā ua hoʻolilo hou i ka hoʻihoʻi hou ʻana i ke kino.

Eia kekahi, ʻo ka hoʻohana wā wā o nā mea i wehewehe ʻia e hiki ai i ka pale ʻana i ka hoʻomaka ʻana o ka maʻi mellitus i ka poʻe i hōʻino ʻia. ʻO ia ke kumu no ka turmeric i loko o ka maʻi ʻaina ke ʻokoʻa loa i ka hoʻohui ʻana o ka meaʻai. He aha nā ʻāpana me kona hoʻohana?

E pili ana i nā kūleʻa

No kēlā me kēia ʻano maʻi o ka maʻi maʻi, ua like nō nā kukuna turmeric. No ka laʻana, hiki iā ʻoe ke hana i kahi kīʻī maikaʻi loa, kahi e loaʻa ai nā meaʻai i ʻekolu: ʻekolu mau kime o ke kīwī ʻeleʻele, he hapa hapaha o ke kōmina, ʻelua mau kime turmeric a me ʻekolu mau ʻoki liʻiliʻi o ka luila.

Eia kekahi, kefir, ka meli a me ka waiū e momona ai e pono e hoʻohui i loko o kēia tī - pono nā ʻāpana āpau i ka maʻi maʻi.

Hoʻomoe ʻia ka ʻaʻa e like me ka algorithm aʻe nei: ua ninini ʻia ka turmeric me ka wai kō, me ka kīwī ʻeleʻele, nāʻaila, ka luina a me ka meli. Hoʻopili maikaʻi ʻia kēia mau mea a pau, hoʻonaninani a hoʻohui ʻia ke kefir. Hiki ia ke hoʻohana i ke kīwī i ke kakahiaka a i ke ahiahi, hoʻokahi aniani i kēlā me kēia. Hiki iāʻoe ke hoʻomākaukau i ka pudding oʻa me ka turmeric, he mea maikaʻi no nā maʻi maʻi.

Kālepala i ʻokiʻoki a me ka iʻa (ʻoi aku ka momona momona) Hoʻopili ʻia kēia mau mea i loko o ka pā i ʻaila me ka aila ʻaila a uala no ka mau minuke he ʻumi mau minuke. ʻ :lelo aʻe:

ka malo i hoʻoohulu ʻia me ka lau o ka ʻala ʻia i kāwili ʻia me ke koena o nā mea pono (hua manu, nā mea kanu, turmeric, ʻono kuluma a me ka pata).
waiho ʻia i kahi pā palaoa kūikawā.

Hoʻomaka kahi kīʻaha ma kahi mahana ma kahi o 180 mau kekona no 50 mau minuke. E pōmaikaʻi maoli nō ia no ka maʻi diabetes a hāʻawi i kahi manawa ʻaʻole wale e hoʻopiha ʻia i ke kino, akā e hoʻomaikaʻi pū ʻia nō hoʻi me nā mea waiwai.

Ke hoʻomaʻamaʻa ʻana i kahi keiki me ka maʻi type kīnā 1 me ka insulin dilalog Humalog: ʻike ʻo Polani

Lawe mākou i kāu manaʻo i kahi unuhi mai English mai kahi ʻatikala a nā kauka Polani i paʻi ʻia ma Kepakemapa 2012. ʻO kēia kekahi o nā mea waiwai pono e hoʻoneʻe ʻia i ka insulin. ʻO nā mea heluhelu o kā mākou pūnaewele, kahi o nā pākeke e mālama i ko lākou maʻa me kaʻai haʻahaʻa, pono lākou e huehue i ka insulin, no ka mea, he nui loa nā dosis. Eia naʻe, ke ʻano nā lāʻau lapaʻau, me nā mea hana o ka insulin a me nā ʻili, e pale ʻole i kēia kumuhana. E heluhelu i kā mākou ʻōlelo ma ka lalo, ma hope o ka pauku o ka ʻatikala.

No nā kamaliʻi liʻiliʻi me nā maʻi type 1, ʻokoʻa ka nui o ka lā o ka insulin i ka emi ma lalo o nā hui he 5-10. ʻO kēia ka mea e pono i nā mea maʻi i kēlā me kēia lā e hoʻokomo i ka emi iho ma mua o 0.05-0.1 ml o ka insulin i ka neʻe o ka 100 PIECES / ml. Pono kekahi mau keiki i ka 0.2-0.3 PIECES o ka bolus (pōkole) insulin e uhi i ka 10 kalama o nā mea momona e ʻai ai. He helu waiwai nui kēia, ʻo ka microscopic dosis o 0.002-0.003 ml o kahi hoʻonāʻana i ka insulin i kahi paona o 100 PIECES / ml.

No ke aha e pono ai au e hoʻoheheʻe i ka insulin

Inā makemake ʻia nā ʻaina haʻahaʻa o ka insulin e mālama i ka maʻi diabetes, hana kēia i nā pilikia i ka wā e hoʻāʻo ai e hōʻoia i ka hoʻokele kūpono a me ka paʻa o ka ʻōpū e like me ka syringe a i ʻole ka pamu insulin. I loko o nā popo, pana pinepine kahi mea hoʻowalewale.

No ka mālamaʻana i nā hui pū, ua hoʻohana maikaʻi kā mākou mea heluhelu iā DiabeNot. Ke ʻike nei i ka kaulana o kēia huahana, ua hoʻoholo mākou e hāʻawi iā i kou makemake.

Hōʻikeia ke ʻano maʻi maʻi type 1 i nā keiki ma mua o nā makahiki mua. No laila, ʻo ka pilikia o ka hoʻokele ʻana i nā papa haʻahaʻa haʻahaʻa o insulin e pili i ka nui o nā mea maʻi. ʻO ka maʻamau, hoʻohana ʻia ka insulin lyspro (Humalog), i hoʻoheheʻe ʻia me kahi wai wai kūikawā e hoʻolako ʻia e ka mea hana, e hoʻohana ʻia no ka ʻohi o ka insulin insulin i nā pēpē. Ma kēia moʻolelo, ke hōʻike nei mākou i ka ʻike o ka hoʻohana ʻana i ka insulin lyspro (Humalog), i hoʻoheheʻe ʻia me ka paʻakai 10 mau manawa - i kahi ʻono o 10 PIECES / ml, no ka hoʻomau ʻana i ka insulin insulin i kahi keiki liʻiliʻi.

ʻO ka papahana mālama maʻi diabetes type 1 no nā pākeke a me nā keiki
ʻAno meaʻai maʻiʻai 1
ʻO ka manawa mele a pehea e hoʻonui ai iā ia
ʻO ke ʻano o nā inikini insulin ʻeha
Hana ʻia ka maʻi diabetes type 1 i kahi keiki me ka ʻole o ka insulin e hoʻohana ana i kaʻai kūpono. Nīnauele me ka ʻohana.
Pehea e hoʻolohi ai i ka luku ʻana i nā keiki

No ke aha ʻoe i hoʻoholo ai e hoʻāʻo e hoʻoheoʻe iā Humalog me ka paʻakai?

Ua kamaʻilio kekahi keikikāne i mau makahiki he 2.5 mau makahiki mai ka maʻi type 1 no nā mahina 12, ʻoiai, mai ka hoʻomaka ʻana e mālama ʻia me ka ʻohi ʻana i ka insulin. Ua hoʻohana mua lākou i ka insulin NovoRapid, a laila hoʻololi i Humalog. He ʻoluʻolu maikaʻi ʻole ke keiki, a ua kokoke kona kiʻekiʻe a me ke koʻikoʻi ma lalo o ka pae maʻamau no kona makahiki a me kāna kāne. Hemoglobin Glycated - 6.4-6.7%. ʻO nā pilikia ʻepekema me ka pauʻole o ka insulin e hele pinepine - i mau manawa i ka hebedoma. Ma muli o kēia, hiki ke hoʻohana ʻia i kēlā me kēia infusion set i nā lā 2 aʻe. ʻO ke kahe koko i ke kō kōʻai koko ua kiʻekiʻe (9.6 ± 5.16 mmol / L), ua kau ʻia ke kōpaʻa 10-17 mau manawa i ka lā. ʻO nā helu o ka insulin he 4.0-6.5 IU i kēlā me kēia lā (0.41-0.62 IU / kg koʻikoʻi kino), kahi he 18-25% he basal.

Hana ʻia no ka maʻi maʻi me ka insulin: e hoʻomaka ʻoe ma aneʻi. Nā ʻano o insulin a me nā lula no ka mālama ʻana.
He aha nā ʻano o ka insulin e hoʻokomo ai, i ka manawa a me nā mea hemo. Nā kumumanaʻo no ka maʻi type 1 a me ke ʻano type type 2.
Pehea e hana ai i nā inikini insulin me ka hōʻeha ʻole. ʻIquelelo loea subkutaneth
ʻO nā syringes Insulin, nā peni syringe a me nā pono. ʻO nā mea ʻili maikaʻi ʻoi aku ka maikaʻi e hoʻohana.
Lantus a me Levemir - ka lōʻihi o ka hana. E hoʻohana i ke kō i ke kakahiaka ma ka ʻōpū ʻole
Ultrashort insulin Humalog, NovoRapid a me Apidra. ʻO ka wīwī pōkole kanaka
ʻO ka heluʻana o ka hoʻonaninani o ka insulin ma mua o ka papaʻaina. Pehea e hoʻohaʻahaʻa ai i ke kō i ke kūkaʻi inā ua lele
Pehea e hoʻoheheʻe ai i ka inika e pololei i ke kaha ʻana i nā ʻōkuhi haʻahaʻa
ʻO ka paukena Insulin: pros a me nā mea kū.Hoʻomaʻa i ka insulin

ʻO nā pilikia i hoʻokaʻawale iā mākou e hoʻāʻo e hoʻoheheʻe i ka insulin me ka saline, penei:

ʻAʻole i loaʻa ka ʻenehana "hōʻailona" hoʻoheheʻe insulin mai ka mea hana.
Hōʻike ka mea maʻi i ka hoʻonui pinepine i ka pae o ka bilirubin a me nā kūmole bile i ke koko. Hiki i kēia ke kupu aku i ka preservatives i loko o ka insulin a me ka proprietary dilution fluid (metacresol a me nā phenol) e hoʻopōʻino i kāna ate.

Ua ʻae ke Komite Ethics i ka hoʻāʻo e hoʻohana i ka insulin i hoʻohemo ʻia me ka paʻakai no ka mālama ʻana. Ua hoʻopaʻa inoa nā mākua i kahi palapala hōʻoia ʻokoʻa. Ua loaʻa iā lākou nā ʻōlelo kikoʻī e pili ana i ka hoʻomālamalama ʻana i ka inikini me ka paʻakai a pehea e hoʻonohonoho ai i nā hoʻonohonoho o ka paukena insulin.

Nā hopena o ka hoʻomake ʻana i ka inika insulin me ka insulin i hoʻoheheʻe ʻia

Ua hoʻomaka nā mākua i ka hoʻohana ʻana i ka maʻi pulu me ka insulin, i hoʻoheheʻe ʻia me ka paʻakai 10 mau manawa, ma ke kumu outpatient, i.e. ma ka home, me ka mālama ʻole ʻana e ka poʻe loea. ʻO kahi papa hana o ka insulin dilalog ua hoʻomākaukau hou ʻia i kēlā me kēia 3 lā. I kēia manawa, me ka hoʻohana ʻana i kahi pōpoki insulin, 10 mau manawa hou aku i hoʻopaʻa ʻia i loko o ke kino o ke pēpē ma mua o ka maoli o ka insulin.

Mai nā lā mua o ka mālama ʻana i ka maʻi diabetes ma lalo o ka hoʻoponopono hou mai, ka nui o ka pilikia o nā pilikia ʻenehana me kahi lāʻau o ka insulin. Ua emi ka nui o ke kō koko a hiki i kahi wānana, a hiki i 7.7 ± 3.94 mmol / L. He mau kuhikuhi kēia e like me nā hopena o ke ana ʻana i ka kōpaʻa o ke koko 13-14 mau manawa i ka lā. No 20 mau mahina e hiki mai ana, ua ʻike ʻia ka nane ʻana o ka cannula o ka pākia e nā crystals insulin. ʻO kekahi hanana ʻano o ka hypoglycemia koʻikoʻi (ua loaʻa ke kō i ke koko he 1,22 mmol / L), e koi ai i ka lawelawe ʻana o ka glucagon. I kēia hihia, ua nalowale ke keiki i ke hoʻomaopopo ʻana no nā minuke 2-3. ʻO ka hemoglobin Glycated i nā mahina 15 mua he 6.3-6.9%, akā ma nā mahina 5 e hiki mai ana ua hoʻonui ʻia ʻo 7.3-7.5% kū'ē i ke kua o nā hopena maʻamau.

ʻO nā dosis o ka Humalog insulin, i hoʻoheheʻe ʻia he 10 mau manawa, a lawelawe ʻia me ka pākī, he 2.8-4.6 U / lā (0.2-0.37 U / kg kaupaona kino), kahi o 35-55% he kumu kaukaʻi i ka makemake a me ka hiki ʻana o kahi maʻi ʻeha. Ke nele ka nele o ke keiki, a pōʻino kēia i kona kaohi ʻana o ke koko koko. Akā e ulu ana ia ma kahi maʻamau, loaʻa i ke kiʻekiʻe a me ke kaupaona, ʻoiai ke mau nei kēia mau kuhikuhi ma ka palena haʻahaʻa o ke ʻano o ka makahiki. ʻO ka pae o ka bilirubin a me nā kumikini bile i ke koko i hōʻemi i ka maʻamau. ʻO ka loli o ka pilikia o ka ʻenekona me kahi pami insulin e hōʻemi nui loa. Hauoli nā mākua. Hōʻole lākou e hoʻoneʻe i ke keiki i ka insulin i ka hoʻokaʻawale ʻana o 100 IU / ml.

Ua noʻonoʻo mākou i hoʻokahi hihia wale nō, akā maikaʻi paha ko mākou ʻike no nā hana ʻē aʻe. Manaʻo mākou e hoʻolilo i ka insulin Humalog 10 mau manawa no ka hoʻohana ʻana me ka inika insulin-pump e kōkua paha i ka hoʻokō ʻana i nā pilikia loea. Ua lilo kēia ʻano hana e palekana ai no kahi keiki e pono ai i nā paukū i ʻole ka insulin. ʻO ka mea nui i ka hoʻomaʻamaʻa holomua ke hui pū me nā mākua a me ka mālama kiaʻi ʻana i ke kaʻina hana e nā loea. Hiki ke hele a ka hana o ka hoʻohuihua 'ana i ka insulin manawa e hoʻomaka' ana nā lulaʻenekini e hoʻomau kaʻinaʻana i nā keiki ʻōpio. No ka kiʻi ʻana i nā hopena hope loa, pono hoʻi nā noiʻi, a me nā ʻōlelo hoʻi mai nā mea hana mai insulin.

Nā manaʻo ma ka pūnaewele Diabet-Med.Com

No nā mea pōkole a me ka ultrashort o ka insulin, ʻaʻole i ʻāpono ʻia kēia hana e nā mea hana, akā ʻaʻole naʻe i pāpā ʻia. I loko o nā papa ʻomaʻi, ʻike ʻike ʻoe i ka nui a i ʻole nā hopena maikaʻi aʻe. Hiki iā ʻoe ke hoʻololi mai Humalog i ka Actrapid ma mua o kahi pāʻina e hana maʻalahi ana me ka hoʻomaʻemaʻe maikaʻi. Akā inā makemake ʻoe e kaohi maoli i ka maʻi maʻamau i kahi keiki, a laila pono ʻoe e hoʻohemo pū kekahi.

Ua hōʻike ʻia no ka hoʻāʻo ʻia ʻana o nā kamaliʻi ʻōpio me ke ʻano type type 1 me ka insulin ka mea e hiki ai iā lākou ke kaha i nā dosis liʻiliʻi maʻamau. A inā e hoʻokau mākou i kā mākou papa lāʻau lapaʻau ʻano type 2 a i ʻole nā papa lāʻau lapaʻau ʻano 1, ʻo ia hoʻi, e ukali i kahi meaʻai haʻahaʻa-haʻihaʻi, a laila me ka hopena kiʻekiʻe ʻaʻole wale nā keiki akā ʻo ka pākeke hoʻi pono e hoʻomoe i ka insulin. No ka mea inā ʻoe e hoʻolauna i nā dosis kiʻekiʻe o ka insulin, e alakaʻi ia i nā pika i ke kō koko koko a me nā hihia pinepine o ka hypoglycemia.

ʻO ka mea pōʻino, kūwaho ʻole ka lāʻau lapaʻau kuʻuna o ke kumuhana o ka insulin. I kēia manawa, ka mea hoʻolaha nui loa e pili ana i ka mālama ʻana i ka maʻi maʻi i nā ʻāina ʻ Russianlelo Lūkini, ʻo ia ka hoʻoponopono ʻōlelo ʻelua ʻelua i hoʻoponopono ʻia e I. I. Dedov a me M. V. Shestakova.

He pepa ʻōpiopio paʻa loa kēia, kokoke i 1,400 mau ʻaoʻao. Auwe kēia, ʻaʻole ia i haʻi i kahi huaʻōlelo e pili ana i ka hoʻoheheʻe ʻana i ka insulin, ʻoiai ma ka pauku e pili ana i ka mālama ʻana i ka maʻi type kīpopeke i nā keiki ʻōpio loa. ʻAʻole e haʻi ʻia i nā pākeke. ʻAno hōʻole loa nā mea kākau i kaʻai haʻahaʻa-haʻahaʻa, ʻoiai ka mea ʻo ia ka ala maikaʻi loa kēia e pale i ke kō o ke koko a pale i nā hōʻeha o ka maʻi maʻi. He pupule kolokole kēia.

Ma ke kaulike, ʻike mākou i ka huhū nui o ka lehulehu e hele nei ma waho. ʻAʻole nā kamaʻilio ʻōlelo Pelekane a me nā puke e pili ana i ka mālama ʻana i ka maʻi diabetes. Hiki iaʻu ke koi wale iā ʻoe e aʻo i kā mākou moʻomeheu koʻikoʻi, "Pehea e hoʻoheheʻe ai i ka Insulin i nā pauku haʻahaʻa maʻalahi." E hoʻohana i nā hana i hōʻike ʻia ma ka hoʻomaʻamaʻa hoʻomaʻamaʻa, a hoʻāʻo paha iā ʻoe iho.

I ka makahiki 1970, ua kuʻi ka lāʻau lapaʻau i ka ʻike ʻana o nā mika glucose koko home no ka liʻiliʻi o 5 mau makahiki, e hiki ai i nā maʻi maʻi maʻi kūʻokoʻa ke ana kūʻokoʻa i kā lākou koko koko. I kēia mau makahiki āpau, ua ʻōlelo mai nā kauka me ka maʻi diabetes, e mālama ana i ke kōpaʻa koko ma ke ʻano maʻamau e like me ka poʻe olakino maikaʻi ʻole a he pōʻino. Heluhelu i ka ʻōlelo ninaninau o Dr. Bernstein ma nā kikoʻī hou aku. I kēia mau lā, hana hou ka mōʻaukala me kahi meaʻaiʻai haʻahaʻa-ʻona e kāohi i ka maʻi diabetes a me ka type 2.

E heluhelu i ke kumu ʻaʻole mākou e koi ʻana i ka hoʻohana ʻana i kahi pami a i ka insulin, ʻoiai no nā kamaliʻi ʻōpio me ke ʻano maʻi type 1. E lawe i kāu pēpē ma kaʻai haʻahaʻa-pahu a ʻoi aku ka nui o ka ʻōpū. Hoʻololi i ka syringes insulin me ka paukena e aʻo wale ʻia inā aʻo nā lāʻau i ke ana e hoʻopaʻa i ke kōpaʻa koko a hoʻokaʻawale i ke kinikini o ka insulin e like me nā hopena o kēia mau ana. I loko o kaʻatikala, ʻo nā mea hoʻomehana hoʻomehana holomua o ka insulin i ka wā e hiki mai ana ua kapa ʻia ʻo "nā ʻōnaehana ʻoiʻi paʻa." A eia nō naʻe, ʻaʻole i pau nā pilikia i hāpai ʻia e kumu ʻole iā lākou.

E kōkua ʻoe i kahi nui kaiāulu ʻōlelo Lūkini nui o nā maʻi me ka maʻi diabetes inā e kaʻana like i nā hopena o kāu mau hoʻokolohua ma ka ninini ʻana i ka insulin ma nā ʻōlelo i nā ʻatikala.

Kauka Kauka

Ma hope o ka hoʻokuʻuʻana, ua hoʻololi nā mākua i ka papaʻa 9 i ʻōlelo ʻia me kahi papa haʻahaʻa-haʻahaʻa o 6-8 XE, hoʻopau loa i ka cereal, berena, nā hua momona, nā kō, nā mea inu āpau me ke kō. Hoʻopiliʻia nā mea inu alkaline a me nā hoʻomaʻamaʻa pilikino.

Mai ka lā 07/07/2016, i mea e hoʻihoʻi ai i ka make huakaʻi, ua hoʻohana nui ʻia nā kaiʻai o Phoenix Fohow (monosaccharides, disaccharides, cordyceps-biological biological) e like me ke kānāwai, hoʻomaʻemaʻe, a me nā kumumanaʻo.

Ke emi nei, me ka emi ʻana o ka glycemia, ua emi nā ʻōpū o ka insulin. Ma hope o 2 mau mahina, ua hiki i ka mea maʻi hoʻopau loa i ka therapy insulin. ^ E Ha yM. Mai ka leka a ka makuahine:Iune 10th hōʻole ʻole mākou i ka insulin, ʻoiai ke kūpaʻa nei ka pae kōlea: mai 4.8 a 7 mmol / l, hiki i ka pae o 8.5-9 mmol / l ma hope o ka ʻai ʻana. "

09/10/2016 3 mau mahina ma hope o ka hoʻoneʻe ʻana i ka insulin exogenous: glycated hemoglobin 6 %C peptide 0,53 ng / ml, me kahi papa o 0.79 - 4.19. Hōʻike nā hōʻike e hoʻihoʻi i ka hana o kā lākou insulin.

E hoʻomanaʻo mai i kahi keiki makuahine

08.10.2016
ʻO ka hope, ke kākau nei wau iā ʻoe e pili ana i nā hopena.
ʻO ke keikikāne he 14 mau makahiki, hōʻike ʻia o ka maʻi type o ka lā i Pepeluali 27, 2016, ʻo Glycated hemoglobin 13.8, he maikaʻi nā hōʻike ʻokoʻa o ka antibody (hōʻoia o ka maʻi āpau 1). Ua kau ʻia ke ʻano maʻi Insulin: he 10 mau papa o ka lantus (1 manawa i kēlā me kēia lā) a me 6-7 mau ʻāpana o ka apidra i kēlā me kēia manawa (3 mau manawa i ka lā). Hoʻokuʻu ʻia mai ka haukapila ma Malaki 3 me nā pae koko koko o 6 i ka 12 mau paona.

Ma hope koke o ka hoʻokuʻu ʻana, ua hoʻololi ʻia ka meaʻai: 6-8 XE i kēlā me kēia lā ma kahi o 18-20 XE i ʻōlelo ʻia i kēlā me kēia lā, nā cereals, berena, nā hua momona, nā kō, nā mea inu a pau ma ka honi ua kāpae ʻia. I ka huina holoʻokoʻa, ʻo ke kumu o ka meaʻai o ka: iʻa, iʻa, nā lau, meaʻai, ke kīwī, ke kime, ka ʻaka, nā huaʻala a me nā huaʻala.

Ma ka lā 7ʻApelila, ma ka noi o Kauka Tetyuk, ua hoʻomaka ʻia ke alakaʻi ʻana o Fohow. Ma ka manawa like, lawe lākou i kahi papa o ka acupuncture a loaʻa i kahi mea kūpono a me nā haʻuki kūpono.

ʻO ke kala o ka insulin e emi mau ana, ʻo ia ka mea nui ma muli o ke komo ʻana a me ka "honi", i kekahi manawa ma hope o ka homa o ka maʻi diabetes.

Ma Mei 25, 2016, ka gogus hemoglobin glecated i ka pae o 6.8. Ka paʻa maikaʻi ka nui o ka Sugar me ka ʻole o ka hyper- a me ka hypoglycemia.

I ka Iune 10, ua haʻalele piha mākou i ka insulin, ʻoiai ke kūpaʻa mau nā hilo gula i ka pae mai 4.8 a 7, hiki i ka nui o ka nui o 8,5-9 ma hope o ka ʻai ʻana. Ke loli nei ka hana ʻana o nā lāʻau Fohow a kūlike hoʻi i ka meaʻai.

I ke kauwela, hoʻohui hou nā hua ʻai a me nā mea kanu (he paʻakikī ke kū ʻole, ʻoiai e ʻai ʻia nā keiki ʻelua a pau). Aia nā pīkī, a me ka wai meli, a me nā ʻano hua like ʻole. ʻAʻole hiki i nā mea kanu i nā mea kanu (ʻoi loa ke anu i loko o ka uala), akā ʻaʻole mākou e ʻai i nā mea kanu mashed ma ke kumu.

Huina nā huina no Kepakemapa 10: glycated hemoglobin 6 ʻāpana, c-peptide 0.53 mau ʻāpana, me kahi ʻano o 0.79 - 4.19. Ua lilo ke kaila o nā huahana Fohow i ke kumu maʻamau ʻaʻole wale no ka wahine ʻōpio i hōʻike ʻia ma luna nei, akā no kā lāua mau keiki ʻelua.

Nā Kauka 10.09.2016 3 mau mahina ma hope o ke hoʻopau ʻana i ka insulin exogenous: hemoglobin glycated 6,0 % ma ka maʻamau (2.0 - 6.0), C-peptide 0,53 ng / ml ma ke kapu (0.79 - 4.19).

12/17/2016 Hoʻomohala i 6 mau mahina ma hope o ka hoʻokuʻu ʻana o ka insulin exogenous: hemoglobin glycated 5,6 % (2.0 - 6.0), C-peptide 0.88 ng / ml (0,79 – 4,19). He mea maʻamau nā hōʻailona ʻelua, e hōʻike ana i ka hoʻihoʻi hou ʻana o ka hana pancreatic. ^ E Ha yM. ʻO ka hana e hoʻomaikaʻi maikaʻi i ka meaʻai me ka mālama ʻana i ka hopena.

ʻO nā pathogenesis o ka maʻi maʻamau

Hōʻike Gene - 2 mau gen mutant i ka chromosome 6th. Pili lākou i ka HLA-ʻōnaehana, ka mea e hoʻoholo ai i ka pane ʻana o ke kino a me nā cell beta i kekahi ʻano hypertension.
ʻ theorylelo i ka maʻi (a maʻi viral viral in people predisposed to diabetesabetly bohoa or a hoʻonā ʻia of the beta cells or lead to the persistence of the virus with the development of autoimmune reaction in islet tissue.)

ʻO ke kumu ke pau ʻole o ka nele o ka insulin.

ʻO ka hiki ʻole o ka glucose e komo i nā kaila o ka insulin e hilinaʻi i ka ikaika o ka ikehu, ka hopena o ka lipolysis nui a me ka proteolysis, i hoʻopili ʻia me ka uku nui. ʻO nā kūlana o ka hemahema o ka insulin a me ka hemahema o ka ikehu, ua disinhibited ke kūkulu ʻana o nā hormone contrainsular, ka mea, ʻoiai ke hoʻonui nei i ka glycemia, hoʻonāukiuki i ka GNG. ʻO ka hoʻonuiʻana i ka lipolysis i ka adipose tissue e alakaʻi i ka hoʻonui nui i ka neʻe o ka FAs. Me ka nele o ka insulin, ua paʻa ka hiki i ka liposenthetic o ka ate, a hoʻomaka nā FA free e pili i ka ketogenesis. ʻO ka hōʻiliʻili o nā kino ketone e alakaʻi i ka hiki ʻana o ka ketosis maʻi maʻi, a i ka wā e hiki mai ana - ke ketoacidosis. Me ka ulu holomua o ka hoʻōho a me ka acidosis, hoʻomohala kahi coma, kahi i ka nīlo ʻole i ka insulin a me ka rehydration e pau ai i ka make.

✧ lōʻihi-hana - Lantus (ka hoʻomaka ʻana o ka hana ma hope o 4 mau hola, ka lōʻihi o ka hana - a hiki i 28 mau hola).

HE ANO O KA INSULIN
■ Ke hoʻololi nei i ka insulin hana pōkole i kahi inikua insulin (no ka laʻana, ka Lizpro insulin) e ʻae i ka hoʻoikaika ʻana o kahi hoʻoponopono ʻai no nā maʻi maʻi maʻi pinepine e hoʻololi i ia ma muli o ka hana.
■ Hoʻomaka koke ka hopena o ka insulin Lizpro ma hope o ka loaʻa ʻana, no laila hiki ke lawelawe koke ʻia ka lāʻau lapaʻau ma mua o a i ka wā o ka pāʻina.
■ Ma nā hoʻokolohua hoʻokolohua, ʻaʻole i hōʻike i ka insulin Lizpro i ka holomua o ka maʻi maʻi ma ka hoʻohālikelike ʻana i ka insina pono engine i hana ʻano pōkole.
■ ʻAʻole i kuhikuhi ʻia nā inikua Insulin no ka hoʻohana ʻana i nā keiki ma lalo o 12 mau makahiki a me nā wahine hāpai.
KA MOOLELO KA HUI LOA
■ Kūkulu ʻia kahi ʻili o ka ʻili i ka wahi i hiki ʻia ai ke holo pono ʻana ma lalo o ka ʻili a ʻaʻole i loko o ka ʻili o ka ʻiʻo. Pono ka laulā o ka ʻili, pono ke komo i ka ʻili ma ke kihi o 45-60 °.
■ E pale pono nā wahi ʻili poloka i ke koho ʻana i kahi pūnaewele ʻona. ʻAʻole hiki ke hoʻololi ʻia nā wahi i hiki ʻia ke loli.
■ ʻAʻole e hoʻokomo i lalo o ka ʻili o ka poʻohiwi.
■ Pono e hoʻokomo ʻia nā insulins maʻa pōkole i loko o ka kiko momona o ka ʻōpū o ka ʻōpū o ka ʻōpū pale 20-30 mau minuke ma mua o ka ʻai ʻana (e lawelawe ʻia ana ka inika insulin ma mua o ka ʻai).
■ Hoʻokomo ʻia nā insulins lōʻihi e hana ana i ka momona o ka ʻōpū o nā ʻūhā a i ʻole nā ʻokiʻoki.
■ Hāʻawi i nā inikini insulin-short-acting (humalog a Novorapid) e hāʻawi koke ʻia i mua o ka papaʻaina, a inā pono, i ka wā i ka manawa ai a ma hope o ka ʻai.
■ E wehewehe pono ʻia ka mea maʻi e hoʻonui ka wela a me ka hoʻomaʻamaʻa i ka piʻi o ka absorption o ka insulin, a hoʻemi ʻia ka anu.
■ Hiki i ka syringe like a me ka lāʻau e hiki ke hoʻohana i nā manawa 4-6 i nā lā 2-3.
■ Nā keiki āpau a me nā ʻōpio me nā maʻi diabetes type 1, nā wahine hāpai me ka maʻi diabetes, nā mea maʻi me ka ʻike maka a me ka hōʻemi ʻana o nā haʻahaʻa haʻahaʻa ma muli o ka maʻi maʻi e hāʻawi ʻia me nā injectors insulin (syringe penens)!
NANO KIKAI ANA I KE KAI MAUI I INSULIN
■ Hoʻonui ka maʻi maʻi ʻana a i ʻole ka pilikia ʻē i ka pono o ka insulin.
■ Hoʻonui ka hana kino i ka hoʻohana ʻana i mea glucose a hiki ke kōkua i ka hypoglycemia inā ʻaʻole i hōʻemi ʻia ka nui o ka insulin a i ʻole ka lawe ʻia aʻe i nā mea hou aʻe.
■ Somogy Phenomenon: Intog-induced hypoglycemia e hoʻihoʻi i ka hoʻokuʻu ʻana o nā hormones contrainsular (adrenaline, cortisol, ulu ulu a me ka glucagon), ka mea i manaʻo ʻia he kumu o ka hyperglycemia. ʻO ka ʻikeʻole i kēia kumu o ka hyperglycemia a me ka hoʻonui ʻana i ka mahele o ka insulin e alakaʻi i ka hypoglycemia koʻikoʻi hou aku. ʻO ka hypoglycemia i ka wā hiamoe ka mea i ʻike ʻole ʻia e ka piʻi ʻana o ka neʻe ʻana o ka hookeoke ʻana i ka ʻai koko, malia paha ma kēia hihia, kahi hōʻemi o ka maʻi o ka insulin e hiki ai iā ʻoe ke hoʻoponopono i ka kakahiaka hypoglycemia.
■ ʻO ka hanana o ka "kakahiaka kakahiaka" (nānā i ka maʻi maʻamau a me ka maʻamau) - ke piʻi nui o ka glucose koko ma waena o 5 a 7 o kakahiaka, i kumu ʻia e ka hypersecretion o ka ulu ulu ʻana i nā hola nui me ka hypoglycemia ma mua.
KOMONO O KA INSULIN THERAPY
■ Hypoglycemia.
■ Nā hanana kūloko a me nā ʻōhua kūleʻa (ʻaʻole loaʻa pinepine loa i ka hoʻomaka ʻana o ka insulin kanaka).
■ Hiki i nā puka Tumor ke loaʻa i ka iwi fibrous a me ka adipose ka heleʻana ma ka wahi i hiki ke hoʻonāukiuki i ka insulin, ma muli o ka hopena lipogenic kūloko o ka insulin ma nā momona momona. Hiki i nā ʻōhumu ke hōʻemi i nā nui inā e pani ʻia ka ʻōpū ma nā wahi o lipohypertrophy.

ʻO ka hoʻomaʻamaʻa ʻana no ka maʻi type 1 i ka israel